Idiopathic multicentric Castleman disease: A case report
DOI:
https://doi.org/10.71152/ajms.v16i8.4623Keywords:
Multicentric Castleman disease; Lymphadenopathy; Lymphoproliferative Disorders; Interleukin-6Abstract
Castleman disease is a rare disease affecting lymph nodes and is considered a non-clonal lymphoproliferative disorder. It has variable clinical presentation and is divided into clinical and histopathological subtypes. Careful evaluation of history and blood investigations contributes to the diagnosis but histopathology remains the precise modality. Treatment involves excision of the affected lymph node in unicentric type of Castleman disease whereas monoclonal antibodies and steroids remain the mainstay of treatment in multicentric Castleman disease. We are presenting a case of 41-year-old female who was on treatment for deep vein thrombosis, presented with generalized lymphadenopathy, investigated for immunoglobulin G4 related disease and lymphoma which was finally proved as idiopathic multicentric Castleman disease.
Downloads
Downloads
Published
Versions
- 2025-08-26 (2)
- 2025-08-01 (1)
How to Cite
Issue
Section
License
Copyright (c) 2025 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
